Literature DB >> 9523102

The vitreous protein concentration is increased prior to neovascularization in experimental ROP.

B A Berkowitz1, K A Roberto, J S Penn.   

Abstract

PURPOSE: To test the hypothesis that the vitreous protein content is altered prior to the development of neovascularization in an experimental model of retinopathy of prematurity (ROP).
METHODS: Newborn rats underwent either a variable oxygen exposure or room air exposure following birth. On day 13 or 14, two days prior to neovascularization, the steady state vitreous and plasma total protein levels in room-air controls or variable-oxygen-exposed newborn rats were determined; similar measurements were also made for control adult rats.
RESULTS: There was a significant difference (P < 0.05, 2-tailed t-test) in the vitreous protein concentration between the age-matched control and experimental newborn rats. The protein level in the ROP rat plasma was not significantly (P > 0.05) different from that in the age-matched control animals. The vitreous-to-plasma-protein ratios of both the control and ROP newborn animals were significantly greater (P < 0.05) than that in the adults.
CONCLUSIONS: The results of this study demonstrate, for the first time, increased vitreous protein levels prior to the development of neovascularization in the newborn rat model of ROP. In addition, developmental changes in vitreous protein levels were identified. The role of developmental and pathologic alterations in the blood-ocular barriers in this study is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9523102     DOI: 10.1076/ceyr.17.2.218.5604

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  7 in total

1.  In vivo assessment of aqueous humor dynamics upon chronic ocular hypertension and hypotensive drug treatment using gadolinium-enhanced MRI.

Authors:  Leon C Ho; Ian P Conner; Chi-Wai Do; Seong-Gi Kim; Ed X Wu; Gadi Wollstein; Joel S Schuman; Kevin C Chan
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-24       Impact factor: 4.799

2.  Delivery of SAR 1118 to the retina via ophthalmic drops and its effectiveness in a rat streptozotocin (STZ) model of diabetic retinopathy (DR).

Authors:  Vidhya R Rao; Elizabeth Prescott; Namdev B Shelke; Ruchit Trivedi; Peter Thomas; Craig Struble; Tom Gadek; Charles A O'Neill; Uday B Kompella
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-05       Impact factor: 4.799

3.  Genetic difference in susceptibility to the blood-retina barrier breakdown in diabetes and oxygen-induced retinopathy.

Authors:  Sarah X Zhang; Jian-Xing Ma; Jing Sima; Ying Chen; Mark S Hu; Anna Ottlecz; George N Lambrou
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

4.  Long-term effects of neonatal hypoxia-ischemia on structural and physiological integrity of the eye and visual pathway by multimodal MRI.

Authors:  Kevin C Chan; Swarupa Kancherla; Shu-Juan Fan; Ed X Wu
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-12-09       Impact factor: 4.799

5.  Effect of cyclosporin-A on the blood--retinal barrier permeability in streptozotocin-induced diabetes.

Authors:  A Carmo; J G Cunha-Vaz; A P Carvalho; M C Lopes
Journal:  Mediators Inflamm       Date:  2000       Impact factor: 4.711

Review 6.  Applications of Manganese-Enhanced Magnetic Resonance Imaging in Ophthalmology and Visual Neuroscience.

Authors:  Wenyu Deng; Muneeb A Faiq; Crystal Liu; Vishnu Adi; Kevin C Chan
Journal:  Front Neural Circuits       Date:  2019-05-14       Impact factor: 3.492

Review 7.  Review: magnetic resonance imaging techniques in ophthalmology.

Authors:  Laura Fanea; Andrew J Fagan
Journal:  Mol Vis       Date:  2012-10-12       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.